nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ALB—chronic obstructive pulmonary disease	0.243	1	CbGaD
Probenecid—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.113	0.194	CbGbCtD
Probenecid—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0528	0.0907	CbGbCtD
Probenecid—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0499	0.0856	CbGbCtD
Probenecid—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0398	0.0683	CbGbCtD
Probenecid—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0398	0.0683	CbGbCtD
Probenecid—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0359	0.0617	CbGbCtD
Probenecid—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0331	0.0568	CbGbCtD
Probenecid—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0331	0.0568	CbGbCtD
Probenecid—ALB—Prednisone—chronic obstructive pulmonary disease	0.0258	0.0442	CbGbCtD
Probenecid—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0254	0.0436	CbGbCtD
Probenecid—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0251	0.043	CbGbCtD
Probenecid—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0171	0.0294	CbGbCtD
Probenecid—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0167	0.0287	CbGbCtD
Probenecid—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0163	0.0281	CbGbCtD
Probenecid—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0146	0.025	CbGbCtD
Probenecid—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0143	0.0245	CbGbCtD
Probenecid—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0135	0.0231	CbGbCtD
Probenecid—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00855	0.0147	CbGbCtD
Probenecid—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00807	0.0139	CbGbCtD
Probenecid—SLC2A9—respiratory system—chronic obstructive pulmonary disease	0.00336	0.0989	CbGeAlD
Probenecid—PANX1—connective tissue—chronic obstructive pulmonary disease	0.00326	0.096	CbGeAlD
Probenecid—SLC2A9—connective tissue—chronic obstructive pulmonary disease	0.00296	0.0871	CbGeAlD
Probenecid—PANX1—trachea—chronic obstructive pulmonary disease	0.00274	0.0806	CbGeAlD
Probenecid—PANX1—lung—chronic obstructive pulmonary disease	0.00197	0.0579	CbGeAlD
Probenecid—ABCC6—connective tissue—chronic obstructive pulmonary disease	0.0018	0.0529	CbGeAlD
Probenecid—SLC2A9—lung—chronic obstructive pulmonary disease	0.00178	0.0525	CbGeAlD
Probenecid—SLC16A7—bronchus—chronic obstructive pulmonary disease	0.00163	0.048	CbGeAlD
Probenecid—SLC16A7—trachea—chronic obstructive pulmonary disease	0.00147	0.0431	CbGeAlD
Probenecid—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.0227	CcSEcCtD
Probenecid—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.00116	0.0343	CbGeAlD
Probenecid—ABCC5—bronchus—chronic obstructive pulmonary disease	0.00114	0.0336	CbGeAlD
Probenecid—ABCC6—lung—chronic obstructive pulmonary disease	0.00108	0.0319	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00107	0.0208	CcSEcCtD
Probenecid—SLC16A7—lung—chronic obstructive pulmonary disease	0.00105	0.031	CbGeAlD
Probenecid—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.0199	CcSEcCtD
Probenecid—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.0198	CcSEcCtD
Probenecid—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00097	0.0189	CcSEcCtD
Probenecid—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000929	0.0181	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000904	0.0176	CcSEcCtD
Probenecid—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000888	0.0173	CcSEcCtD
Probenecid—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000888	0.0173	CcSEcCtD
Probenecid—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000862	0.0168	CcSEcCtD
Probenecid—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000838	0.0163	CcSEcCtD
Probenecid—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000791	0.0233	CbGeAlD
Probenecid—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00078	0.0152	CcSEcCtD
Probenecid—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000774	0.0151	CcSEcCtD
Probenecid—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000774	0.0151	CcSEcCtD
Probenecid—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000744	0.0145	CcSEcCtD
Probenecid—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000744	0.0145	CcSEcCtD
Probenecid—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000737	0.0144	CcSEcCtD
Probenecid—ABCC5—lung—chronic obstructive pulmonary disease	0.000737	0.0217	CbGeAlD
Probenecid—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000733	0.0143	CcSEcCtD
Probenecid—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.0143	CcSEcCtD
Probenecid—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.000721	0.0212	CbGeAlD
Probenecid—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000695	0.0135	CcSEcCtD
Probenecid—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.0132	CcSEcCtD
Probenecid—ABCC1—bronchus—chronic obstructive pulmonary disease	0.000675	0.0199	CbGeAlD
Probenecid—SLC16A1—lung—chronic obstructive pulmonary disease	0.00067	0.0197	CbGeAlD
Probenecid—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00062	0.0121	CcSEcCtD
Probenecid—ABCC3—lung—chronic obstructive pulmonary disease	0.000619	0.0182	CbGeAlD
Probenecid—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000617	0.012	CcSEcCtD
Probenecid—ABCC1—trachea—chronic obstructive pulmonary disease	0.000606	0.0178	CbGeAlD
Probenecid—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000594	0.0116	CcSEcCtD
Probenecid—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000594	0.0116	CcSEcCtD
Probenecid—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000593	0.0175	CbGeAlD
Probenecid—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000584	0.0114	CcSEcCtD
Probenecid—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000582	0.0113	CcSEcCtD
Probenecid—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.0112	CcSEcCtD
Probenecid—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000561	0.0109	CcSEcCtD
Probenecid—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000552	0.0108	CcSEcCtD
Probenecid—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000542	0.0106	CcSEcCtD
Probenecid—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.0104	CcSEcCtD
Probenecid—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000533	0.0157	CbGeAlD
Probenecid—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000531	0.0156	CbGeAlD
Probenecid—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00052	0.0101	CcSEcCtD
Probenecid—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000516	0.0101	CcSEcCtD
Probenecid—ABCC4—lung—chronic obstructive pulmonary disease	0.000511	0.015	CbGeAlD
Probenecid—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.0099	CcSEcCtD
Probenecid—Pain—Formoterol—chronic obstructive pulmonary disease	0.000508	0.0099	CcSEcCtD
Probenecid—Pain—Montelukast—chronic obstructive pulmonary disease	0.000497	0.00969	CcSEcCtD
Probenecid—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.00967	CcSEcCtD
Probenecid—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000491	0.00958	CcSEcCtD
Probenecid—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000489	0.00953	CcSEcCtD
Probenecid—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.0095	CcSEcCtD
Probenecid—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000486	0.00948	CcSEcCtD
Probenecid—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00934	CcSEcCtD
Probenecid—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000472	0.00919	CcSEcCtD
Probenecid—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000472	0.00919	CcSEcCtD
Probenecid—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00915	CcSEcCtD
Probenecid—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00915	CcSEcCtD
Probenecid—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000468	0.00912	CcSEcCtD
Probenecid—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000463	0.00903	CcSEcCtD
Probenecid—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000463	0.00903	CcSEcCtD
Probenecid—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000462	0.009	CcSEcCtD
Probenecid—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000461	0.00898	CcSEcCtD
Probenecid—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00896	CcSEcCtD
Probenecid—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00868	CcSEcCtD
Probenecid—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00864	CcSEcCtD
Probenecid—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000437	0.00853	CcSEcCtD
Probenecid—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000437	0.00853	CcSEcCtD
Probenecid—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000437	0.00852	CcSEcCtD
Probenecid—ABCC1—lung—chronic obstructive pulmonary disease	0.000435	0.0128	CbGeAlD
Probenecid—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000428	0.00835	CcSEcCtD
Probenecid—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00819	CcSEcCtD
Probenecid—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00819	CcSEcCtD
Probenecid—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00805	CcSEcCtD
Probenecid—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00802	CcSEcCtD
Probenecid—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00773	CcSEcCtD
Probenecid—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000393	0.00765	CcSEcCtD
Probenecid—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000393	0.00765	CcSEcCtD
Probenecid—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000385	0.0075	CcSEcCtD
Probenecid—SLC22A5—lung—chronic obstructive pulmonary disease	0.000383	0.0113	CbGeAlD
Probenecid—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.00736	CcSEcCtD
Probenecid—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000377	0.00736	CcSEcCtD
Probenecid—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00729	CcSEcCtD
Probenecid—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00729	CcSEcCtD
Probenecid—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00725	CcSEcCtD
Probenecid—Headache—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00725	CcSEcCtD
Probenecid—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000371	0.00723	CcSEcCtD
Probenecid—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00037	0.00721	CcSEcCtD
Probenecid—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00714	CcSEcCtD
Probenecid—Headache—Montelukast—chronic obstructive pulmonary disease	0.000364	0.0071	CcSEcCtD
Probenecid—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00695	CcSEcCtD
Probenecid—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00688	CcSEcCtD
Probenecid—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00687	CcSEcCtD
Probenecid—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00687	CcSEcCtD
Probenecid—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.00685	CcSEcCtD
Probenecid—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00673	CcSEcCtD
Probenecid—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000335	0.00985	CbGeAlD
Probenecid—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00649	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.00627	CcSEcCtD
Probenecid—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00595	CcSEcCtD
Probenecid—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00566	CcSEcCtD
Probenecid—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00536	CcSEcCtD
Probenecid—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00516	CcSEcCtD
Probenecid—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00498	CcSEcCtD
Probenecid—ABCB1—trachea—chronic obstructive pulmonary disease	0.000247	0.00728	CbGeAlD
Probenecid—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00462	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00455	CcSEcCtD
Probenecid—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00434	CcSEcCtD
Probenecid—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.00414	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000203	0.00396	CcSEcCtD
Probenecid—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00395	CcSEcCtD
Probenecid—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00393	CcSEcCtD
Probenecid—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00372	CcSEcCtD
Probenecid—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000186	0.00362	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000185	0.0036	CcSEcCtD
Probenecid—ABCB1—lung—chronic obstructive pulmonary disease	0.000178	0.00523	CbGeAlD
Probenecid—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00336	CcSEcCtD
Probenecid—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00322	CcSEcCtD
Probenecid—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00301	CcSEcCtD
Probenecid—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000149	0.0029	CcSEcCtD
Probenecid—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00287	CcSEcCtD
Probenecid—Headache—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00285	CcSEcCtD
Probenecid—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00271	CcSEcCtD
Probenecid—PANX1—Immune System—IL6—chronic obstructive pulmonary disease	3.68e-05	0.000413	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.68e-05	0.000413	CbGpPWpGaD
Probenecid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.67e-05	0.000412	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.67e-05	0.000411	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.67e-05	0.000411	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.65e-05	0.000409	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.65e-05	0.000409	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.65e-05	0.000409	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.61e-05	0.000405	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.58e-05	0.000401	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.56e-05	0.000399	CbGpPWpGaD
Probenecid—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.55e-05	0.000398	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.51e-05	0.000394	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.5e-05	0.000393	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.000388	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.000385	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	3.43e-05	0.000384	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	3.41e-05	0.000383	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.00038	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.39e-05	0.00038	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.34e-05	0.000374	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.31e-05	0.000371	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.24e-05	0.000363	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.22e-05	0.000361	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.2e-05	0.000359	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.2e-05	0.000359	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	3.19e-05	0.000357	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.18e-05	0.000357	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.09e-05	0.000346	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	3.08e-05	0.000345	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.08e-05	0.000345	CbGpPWpGaD
Probenecid—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	3.07e-05	0.000344	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.04e-05	0.000341	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.01e-05	0.000338	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.01e-05	0.000337	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	3e-05	0.000336	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.98e-05	0.000334	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.000333	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.95e-05	0.00033	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.000327	CbGpPWpGaD
Probenecid—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.86e-05	0.00032	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.85e-05	0.000319	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.84e-05	0.000318	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.83e-05	0.000317	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.82e-05	0.000316	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.81e-05	0.000314	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.8e-05	0.000313	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.79e-05	0.000313	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.79e-05	0.000313	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.79e-05	0.000312	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000312	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.77e-05	0.00031	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.000306	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.71e-05	0.000304	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000302	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.69e-05	0.000302	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.67e-05	0.000299	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.65e-05	0.000297	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.63e-05	0.000294	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.61e-05	0.000293	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.61e-05	0.000292	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.6e-05	0.000291	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.6e-05	0.000291	CbGpPWpGaD
Probenecid—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.59e-05	0.00029	CbGpPWpGaD
Probenecid—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.00029	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.58e-05	0.00029	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.57e-05	0.000289	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.57e-05	0.000288	CbGpPWpGaD
Probenecid—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	2.56e-05	0.000287	CbGpPWpGaD
Probenecid—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	2.55e-05	0.000285	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.54e-05	0.000285	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.54e-05	0.000284	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.54e-05	0.000284	CbGpPWpGaD
Probenecid—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.52e-05	0.000283	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.51e-05	0.000281	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.5e-05	0.000281	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.47e-05	0.000277	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000276	CbGpPWpGaD
Probenecid—ABCC1—Disease—KL—chronic obstructive pulmonary disease	2.37e-05	0.000265	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.36e-05	0.000264	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.35e-05	0.000264	CbGpPWpGaD
Probenecid—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.34e-05	0.000263	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.34e-05	0.000263	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.34e-05	0.000262	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.33e-05	0.000261	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.32e-05	0.00026	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.31e-05	0.000259	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.29e-05	0.000256	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.28e-05	0.000256	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.27e-05	0.000254	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.26e-05	0.000254	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.25e-05	0.000252	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.25e-05	0.000252	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.24e-05	0.000251	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.22e-05	0.000249	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.21e-05	0.000248	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	2.21e-05	0.000248	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.21e-05	0.000248	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.18e-05	0.000245	CbGpPWpGaD
Probenecid—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	2.16e-05	0.000242	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TP53—chronic obstructive pulmonary disease	2.15e-05	0.000241	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.12e-05	0.000238	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.12e-05	0.000238	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.11e-05	0.000237	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.11e-05	0.000236	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.1e-05	0.000236	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.1e-05	0.000236	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.06e-05	0.000231	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.06e-05	0.000231	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.06e-05	0.000231	CbGpPWpGaD
Probenecid—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	2.06e-05	0.000231	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.05e-05	0.00023	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.04e-05	0.000228	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.01e-05	0.000225	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.000223	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.000219	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.95e-05	0.000219	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.95e-05	0.000218	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.94e-05	0.000217	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.93e-05	0.000216	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.92e-05	0.000215	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.88e-05	0.00021	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.000209	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.86e-05	0.000209	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.86e-05	0.000208	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.84e-05	0.000206	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.000206	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.84e-05	0.000206	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.81e-05	0.000202	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000202	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	1.8e-05	0.000202	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000201	CbGpPWpGaD
Probenecid—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	1.77e-05	0.000199	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.76e-05	0.000197	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.76e-05	0.000197	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.73e-05	0.000194	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.72e-05	0.000193	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.000192	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.71e-05	0.000192	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.000191	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.68e-05	0.000189	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.68e-05	0.000188	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000188	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.66e-05	0.000186	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.65e-05	0.000185	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.62e-05	0.000181	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.6e-05	0.00018	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.6e-05	0.00018	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.57e-05	0.000176	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000172	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.000172	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.53e-05	0.000171	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000169	CbGpPWpGaD
Probenecid—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	1.48e-05	0.000166	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.43e-05	0.00016	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.41e-05	0.000158	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000158	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.000157	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.000157	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.39e-05	0.000155	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000155	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.38e-05	0.000154	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-05	0.000153	CbGpPWpGaD
Probenecid—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.36e-05	0.000153	CbGpPWpGaD
Probenecid—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	1.36e-05	0.000153	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.36e-05	0.000153	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	1.33e-05	0.00015	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000149	CbGpPWpGaD
Probenecid—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000149	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	1.33e-05	0.000149	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000147	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.28e-05	0.000143	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.27e-05	0.000142	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.27e-05	0.000142	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.00014	CbGpPWpGaD
Probenecid—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	1.25e-05	0.00014	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000139	CbGpPWpGaD
Probenecid—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000139	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.24e-05	0.000139	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.22e-05	0.000137	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000135	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000134	CbGpPWpGaD
Probenecid—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.000133	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	0.00013	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000129	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000128	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.14e-05	0.000128	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.13e-05	0.000126	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.000125	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.11e-05	0.000125	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000124	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.000122	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000119	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000117	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.04e-05	0.000116	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.000115	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	1.03e-05	0.000115	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.02e-05	0.000114	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.000112	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.96e-06	0.000112	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.61e-06	0.000108	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.6e-06	0.000108	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.55e-06	0.000107	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.47e-06	0.000106	CbGpPWpGaD
Probenecid—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.42e-06	0.000106	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.37e-06	0.000105	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	9.07e-06	0.000102	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.82e-06	9.89e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	8.82e-06	9.88e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.77e-06	9.83e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.67e-06	9.72e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.57e-06	9.6e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.45e-06	9.47e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	8.45e-06	9.47e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.36e-06	9.37e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.36e-06	9.37e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.32e-06	9.32e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.25e-06	9.25e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.08e-06	9.06e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.88e-06	8.83e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	7.86e-06	8.81e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.81e-06	8.76e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	7.71e-06	8.64e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.71e-06	8.64e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.69e-06	8.61e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.47e-06	8.37e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.44e-06	8.33e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.35e-06	8.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.29e-06	8.17e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	7.26e-06	8.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.18e-06	8.05e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.81e-06	7.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.71e-06	7.52e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.18e-06	6.93e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	5.93e-06	6.64e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	5.69e-06	6.37e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	5.44e-06	6.1e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	5.41e-06	6.06e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.15e-06	5.78e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.08e-06	5.7e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.07e-06	5.69e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.95e-06	5.55e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.85e-06	5.44e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.74e-06	5.31e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.74e-06	5.31e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.63e-06	5.19e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.49e-06	5.03e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.43e-06	4.96e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.05e-06	3.42e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.92e-06	3.27e-05	CbGpPWpGaD
